"A concerning trend reveals Gen Z’s increasing reliance on illicitly obtained prescription anti-anxiety drugs like propranolol and pregabalin, seeking an alternative to alcohol for social ease and euphoria, yet exposing themselves to profound health risks and potentially fatal consequences."
Recent studies are shedding light on a disquieting shift in substance use patterns among Generation Z. A growing number of young people are turning to prescription anti-anxiety medications, such as propranolol and pregabalin, not under medical guidance but through illicit channels. This emerging practice is driven by a desire to mitigate social anxiety and achieve a sense of euphoria without the traditional drawbacks associated with alcohol consumption, but it carries significant, often unrecognised, health hazards.
The landscape of youth substance use is undergoing a profound transformation, with emerging data indicating a notable rise in the use of prescription medications for recreational purposes among Generation Z. This demographic, broadly encompassing individuals born between the mid-1990s and early 2010s, is navigating a unique socio-digital environment characterized by unprecedented social pressures, mental health challenges, and immediate access to information – and unfortunately, misinformation – online. The BBC World Service, in a recent exposé featuring Global Health Reporter Jacqui Wakefield, highlighted this critical trend, focusing on the unsupervised use of anti-anxiety drugs like propranolol and pregabalin.
These medications, designed for specific medical conditions and requiring strict physician oversight, are increasingly being sourced through unregulated online platforms and the black market. Propranolol, a beta-blocker, is legitimately prescribed for conditions ranging from high blood pressure and angina to tremors and performance anxiety. It works by blocking the effects of adrenaline, thereby slowing heart rate and reducing physical symptoms of anxiety. Pregabalin, an anticonvulsant and neuropathic pain medication, affects chemicals in the brain that send pain signals and can also be prescribed for generalized anxiety disorder. Both drugs, while effective in their intended therapeutic contexts, carry significant risks when used without a professional medical diagnosis, appropriate dosage, and monitoring.
The motivations behind this trend are complex and multifaceted. One primary driver identified by Jacqui Wakefield is the desire to reduce social anxiety, particularly during nights out and social gatherings. For many young people, the pressure to perform socially, maintain an image, and navigate potentially awkward situations can be overwhelming. Alcohol has long been the go-to social lubricant, but its downsides – the calorie count, the debilitating hangovers, and the loss of control – are increasingly being viewed as undesirable by a generation often more health-conscious and image-aware.
This leads to the allure of a perceived "cleaner" high: a feeling of euphoria and reduced inhibition without the physical and cognitive impairment typically associated with heavy drinking. Young people report seeking the positive social effects of feeling relaxed and confident, but without the caloric intake, the next-day hangover, or the public perception of excessive alcohol consumption. This perspective, however, dangerously overlooks the profound pharmacological effects and potential for harm inherent in these powerful medications. The perception that a pill is a more controlled or sophisticated way to manage social situations is a dangerous misconception.
The ease of access to these prescription-only drugs further exacerbates the problem. The internet, particularly the dark web, encrypted messaging apps, and certain social media channels, has created a vast, unregulated marketplace. Individuals can procure these substances with relative anonymity, often without understanding the origin, purity, or actual dosage of what they are consuming. This black market supply chain introduces additional layers of risk, including the possibility of counterfeit drugs containing unknown, harmful substances, or vastly incorrect dosages that can lead to severe adverse reactions or overdose.
The risks associated with using propranolol and pregabalin without medical supervision are substantial and varied. Firstly, without a proper diagnosis, individuals may be masking underlying mental health conditions that require comprehensive treatment rather than symptomatic relief. Secondly, both drugs have specific contraindications and potential interactions with other medications, supplements, or even pre-existing health conditions. A doctor assesses these factors carefully before prescribing. For instance, propranolol can be dangerous for individuals with asthma or certain heart conditions, while pregabalin can cause dizziness, drowsiness, and is known to be habit-forming.
Specifically, the unsupervised use of propranolol can lead to dangerously low heart rates (bradycardia), hypotension (low blood pressure), and can worsen conditions like asthma or diabetes. Abrupt cessation after prolonged use can also trigger rebound effects, including severe anxiety, tremors, and even cardiac events. For pregabalin, the dangers are perhaps even more acute due to its potential for dependence and addiction. Its GABAergic effects, which calm the nervous system, can lead to severe withdrawal symptoms if stopped suddenly, including seizures, insomnia, and intense anxiety. When mixed with other central nervous system depressants, such as alcohol or opioids, pregabalin significantly increases the risk of respiratory depression, coma, and death.
Beyond the immediate physical dangers, the mental health implications are profound. While initially taken to alleviate anxiety, long-term unsupervised use can paradoxically worsen anxiety and depression, create new dependencies, and disrupt natural coping mechanisms. The "rebound effect" when the drug wears off often leaves users feeling more anxious and distressed than before, perpetuating a cycle of dependence. This cycle can contribute to a deepening sense of despair and, as the BBC episode warns, includes references to suicidal thoughts. This highlights the critical need for appropriate mental health support rather than self-medication with potent pharmaceuticals.
The legal ramifications are also significant. Possessing, buying, or distributing prescription drugs without a valid prescription is illegal in many countries and can result in severe penalties, including fines and imprisonment. Furthermore, the social consequences can ripple through a young person’s life, affecting academic performance, employment prospects, and personal relationships as addiction takes hold or health deteriorates.
Public health experts, including Jacqui Wakefield, emphasize the urgent need for a multi-pronged approach to address this growing crisis. There must be increased awareness campaigns targeting Gen Z about the dangers of unsupervised prescription drug use, alongside enhanced efforts to regulate online drug sales. Crucially, addressing the root causes – the rising prevalence of anxiety and other mental health issues among young people – requires robust, accessible, and destigmatized mental health services. Providing young people with healthy coping strategies and genuine support for their anxieties is paramount to steering them away from dangerous self-medication practices.
In conclusion, the trend of Gen Z turning to unprescribed anti-anxiety medications represents a serious public health challenge. While the motivations may stem from a desire to navigate social pressures and avoid the negative aspects of alcohol, the risks associated with these powerful drugs, when used without medical supervision, are profound and potentially life-threatening. It is a critical reminder that prescription medications are not benign substances; they are potent tools that require professional guidance and respect.
If you or someone you know is affected by any of the issues discussed in this article, or are experiencing distress or despair and need support, please speak to a health professional or an organization that offers support. Details of help available in many countries can be found at Befrienders Worldwide: www.befrienders.org.
